Preclinical evaluations of Norcantharidin liposome and emulsion hybrid delivery system with improved encapsulation efficiency and enhanced antitumor activity.

Zixu LiuLinxuan ZhaoXinyi TanZixuan WuNing ZhouNan DongYu ZhangTian YinHaibing HeJingxin GouXing TangSong Gao

Published in: Expert opinion on drug delivery (2022)

The liposome-emulsion hybrid (LEH) delivery system was potential carrier for NCTD delivery, and LEH could open opportunities for delivery of poorly soluble anticancer drugs, especially drugs that are more hydrophilicity than lipophilicity.

Keyphrases

minimally invasive
cell therapy
drug induced
human health
risk assessment
mesenchymal stem cells
bone marrow